HAZLET, N.J. - May 11, 2026 - PRLog -- In this symposium, HF nurses will be provided with education, through lecture and "real-world" case discussion, that will enable them to 1) use potassium binders effectively and safely with fundamental knowledge about their profiles and clinical trial evidence, and 2) communicate key information to patients about the reasons for initiating potassium binders, and using them long-term with RAAS is to reduce their risk of major adverse outcomes.
Click here for more information
CHAIR
Nancy Albert, PhD, CCNS, CHFN, CCRN, NE-BC
Associate Chief Nursing Officer--Research and Innovation
Clinical Nurse Specialist--Kaufman Center for Heart Failure
Cleveland Clinic
Cleveland, Ohio
FACULTY
Stephanie Barnes, DNP, AGNP-C, CHFN
Clinical Director for Advanced Heart Failure
Duke University Health System
Durham, North Carolina
Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina
Educational Objectives
- Recognize the relationship of hyperkalemia (or fear of hyperkalemia) and underuse and underdosing of RAASis in HF
- Explain the relationship between down-titration or discontinuation of RAASis and clinical outcomes
- Explain the key characteristics of, and clinical evidence with novel potassium binders
- Identify HF patients who would benefit from novel potassium binders for the treatment of hyperkalemia
Target Audience
This educational activity is intended for Heart Failure Nurses.
Educational Grant
This activity is supported by an educational grant from AstraZeneca Pharmaceuticals.
Accreditation and Credit Designation Statements
This activity is provided by the American Association of Heart Failure Nurses (AAHFN). The American Association of Heart Failure Nurses (AAHFN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC) Commission on Accreditation.
Attendees may earn continuing education credits (CEC) by attending the meeting and completing the evaluation for the Annual Meeting sessions. Disclaimer: Learners are advised that accredited status does not imply endorsement by the provider, additional provider, or ANCC of any commercial products displayed in conjunction with an activity. Accreditation Provider Number: ANCC Provider Number: P0398.
Photos: (Click photo to enlarge)
Source: CMEPlanet
Read Full Story - 2026 AAHFN CME Symposium - Maintaining RAAS Inhibition and Managing Hyperkalemia: Expert Insights into Best HF Patient Care | More news from this source
Press release distribution by PRLog
